首页> 外文期刊>Patient Preference and Adherence >Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France
【24h】

Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France

机译:在法国评估患者对人类免疫缺陷病毒疗法的偏好和满意度

获取原文

摘要

Objectives: The objectives were 1) to elicit relative preferences for attributes of antiretroviral therapies (ART) in people living with HIV (PLWH) and 2) to explore satisfaction and adherence with current ART. Patients and methods: We conducted a multicenter cross-sectional study, consecutively enrolling PLWH receiving an ART. The quantitative part estimated the strength of preference for different attributes using an online discrete choice experiment (DCE). DCE data were analyzed using a mixed logit regression model. Qualitative data were collected through individual interviews. A preliminary coding framework was developed which was then further refined and applied during thematic analysis of factors influencing satisfaction and adherence. Results: A total of 101 PLWH took part in the quantitative part and 31 in the qualitative part. Over 90% had an undetectable viral load. Quantitative data revealed a strong preference for a treatment with limited drug–drug interactions, diarrhea and long-term health problems ( P <0.0001), and that did not need to be taken on an empty stomach ( P <0.0001). Patients also preferred to avoid problems associated with treatment failure ( P <0.0001) or one that left them with a higher viral load after the first weeks of treatment ( P =0.044). Differences in CD4 cell count, and pills that must be taken with food were not significant drivers of treatment choice. The strength of these attributes was reflected in the qualitative data, highlighting the importance patients place on treatment efficacy, and also suggesting that some of these attributes may impact adherence. Many factors influencing adherence and satisfaction with treatment were identified, including pill size, worry about sexual transmission and impact on social life. Conclusion: Most of the attributes included in this survey were important to participants when choosing an ART, in particular those related to quality of life, and these should be taken into account in order to optimize adherence and satisfaction.
机译:目标:目标是1)引起艾滋病毒感染者(PLWH)对抗逆转录病毒疗法(ART)属性的相对偏爱,以及2)探索对当前抗逆转录病毒疗法的满意度和依从性。患者和方法:我们进行了一项多中心的横断面研究,连续招募接受ART的PLWH。定量部分使用在线离散选择实验(DCE)估算了不同属性的偏好强度。使用混合logit回归模型分析DCE数据。通过个别访谈收集定性数据。建立了初步的编码框架,然后进一步完善和应用了影响满意度和坚持性的因素的主题分析。结果:总共有101名PLWH参加了定量部分,有31名参加了定性部分。超过90%的病毒载量无法检测。定量数据显示,强烈希望采用药物相互作用有限,腹泻和长期健康问题的治疗方法(P <0.0001),而无需空腹服用(P <0.0001)。患者还倾向于避免与治疗失败相关的问题(P <0.0001)或在治疗的最初几周内使他们承受较高病毒载量的问题(P = 0.044)。 CD4细胞计数的差异以及必须随食物一起服用的药丸并不是治疗选择的重要驱动力。定性数据反映了这些属性的强度,突出了患者对治疗功效的重视,还暗示其中某些属性可能会影响依从性。确定了许多影响依从性和治疗满意度的因素,包括药丸大小,对性传播的担忧以及对社会生活的影响。结论:本调查包括的大多数属性对于参与者选择ART时都很重要,尤其是与生活质量相关的属性,应将这些属性考虑在内,以优化依从性和满意度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号